Accuracy of Case-Based Seroprevalence of SARS-CoV-2 Antibodies in Maricopa County, Arizona.
Am J Public Health
; 112(1): 38-42, 2022 01.
Article
en En
| MEDLINE
| ID: mdl-34936397
ABSTRACT
We conducted a community seroprevalence survey in Arizona, from September 12 to October 1, 2020, to determine the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We used the seroprevalence estimate to predict SARS-CoV-2 infections in the jurisdiction by applying the adjusted seroprevalence to the county's population. The estimated community seroprevalence of SARS-CoV-2 infections was 4.3 times greater (95% confidence interval = 2.2, 7.5) than the number of reported cases. Field surveys with representative sampling provide data that may help fill in gaps in traditional public health reporting. (Am J Public Health. 2022;112(1)38-42. https//doi.org/10.2105/AJPH.2021.306568).
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Prueba Serológica para COVID-19
/
COVID-19
/
Anticuerpos Antivirales
Tipo de estudio:
Prognostic_studies
Límite:
Adolescent
/
Adult
/
Aged
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
País como asunto:
America do norte
Idioma:
En
Año:
2022
Tipo del documento:
Article